Qyuns Therapeutics Co., Ltd. (HKG: 2509)
Hong Kong
· Delayed Price · Currency is HKD
12.00
-1.00 (-7.69%)
Nov 15, 2024, 10:33 AM HKT
Qyuns Therapeutics Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 468.44 | 216.3 | 213.09 | 218.06 |
Short-Term Investments | 0.54 | 0.54 | 0.55 | 0.29 |
Trading Asset Securities | 160.65 | 160.41 | 401.1 | 402.38 |
Cash & Short-Term Investments | 629.63 | 377.26 | 614.73 | 620.72 |
Cash Growth | 2.42% | -38.63% | -0.96% | - |
Other Receivables | 1.53 | 10.57 | 4.04 | 8.65 |
Receivables | 1.53 | 10.57 | 4.04 | 8.65 |
Inventory | 10.83 | 3.77 | - | - |
Prepaid Expenses | 40.68 | 23.03 | 16.23 | 18.45 |
Other Current Assets | 8.96 | 3.7 | 0.94 | 0.44 |
Total Current Assets | 712.62 | 418.33 | 635.95 | 648.26 |
Property, Plant & Equipment | 346.34 | 361.44 | 386.16 | 400.83 |
Other Intangible Assets | 3.84 | 2.35 | 3.05 | 0.38 |
Other Long-Term Assets | 11.92 | 13.47 | 9.94 | 18.02 |
Total Assets | 1,075 | 795.58 | 1,035 | 1,067 |
Accounts Payable | 79.1 | 72.96 | 19.14 | 12.6 |
Accrued Expenses | 25.98 | 31.45 | 24.64 | 19.04 |
Short-Term Debt | 141.94 | 59.6 | 15.9 | - |
Current Portion of Long-Term Debt | 45.27 | 60.1 | 44.61 | 14.87 |
Current Portion of Leases | 1.07 | 1.29 | 1.75 | 0.96 |
Current Unearned Revenue | 67.27 | 0.87 | - | - |
Other Current Liabilities | 22.24 | 25.5 | 16.15 | 22.22 |
Total Current Liabilities | 382.86 | 251.78 | 122.19 | 69.67 |
Long-Term Debt | 311.44 | 224.43 | 232.52 | 274.05 |
Long-Term Leases | 0.21 | 0.63 | 0.47 | 0.39 |
Long-Term Unearned Revenue | 17.06 | 17.38 | 18.02 | 18.66 |
Long-Term Deferred Tax Liabilities | 0.38 | 0.41 | 0.49 | 0.56 |
Total Liabilities | 711.94 | 494.63 | 373.69 | 363.33 |
Common Stock | 222.07 | 210.03 | 180.53 | 166.48 |
Additional Paid-In Capital | 1,012 | 830.18 | 830.18 | 616.23 |
Retained Earnings | -1,093 | -921.36 | -413.61 | -115.42 |
Comprehensive Income & Other | 226.55 | 175.91 | 44.62 | 3.06 |
Total Common Equity | 367.61 | 294.76 | 641.72 | 670.35 |
Minority Interest | -4.84 | 6.19 | 19.7 | 33.82 |
Shareholders' Equity | 362.78 | 300.95 | 661.41 | 704.17 |
Total Liabilities & Equity | 1,075 | 795.58 | 1,035 | 1,067 |
Total Debt | 499.93 | 346.06 | 295.25 | 290.26 |
Net Cash (Debt) | 129.7 | 31.2 | 319.48 | 330.46 |
Net Cash Growth | -59.40% | -90.24% | -3.32% | - |
Net Cash Per Share | 0.61 | 0.15 | 1.80 | 2.84 |
Filing Date Shares Outstanding | 222.07 | 222.07 | 180.53 | 166.48 |
Total Common Shares Outstanding | 222.07 | 210.03 | 180.53 | 166.48 |
Working Capital | 329.76 | 166.55 | 513.76 | 578.59 |
Book Value Per Share | 1.66 | 1.40 | 3.55 | 4.03 |
Tangible Book Value | 363.77 | 292.42 | 638.66 | 669.98 |
Tangible Book Value Per Share | 1.64 | 1.39 | 3.54 | 4.02 |
Buildings | - | 238.73 | 238.73 | 238.73 |
Machinery | - | 188.24 | 178.24 | 168.09 |
Construction In Progress | - | 0.21 | 4.96 | 2.01 |
Source: S&P Capital IQ. Standard template. Financial Sources.